Press contact
Communication Service
Phone: +33(0) 362 263 772
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Our press releases
![](/images/slider170/team05_dots.png)
GenoScreen and Illumina Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis
![](/images/external-link.png)
Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
![](/images/external-link.png)
Deeplex® Myc-TB, a breakthrough innovation to effectively fight tuberculosis
![](/images/external-link.png)
A microbial signature in indoor air associated with severe asthma
![](/images/external-link.png)
Number of new cases in contacts of leprosy patients decreases after dose of antibiotic
![](/images/external-link.png)
Publication of the first comprehensive performance evaluation of the "Deeplex® Myc-TB" test for the prediction of tuberculosis antibiotic resistance
![](/images/external-link.png)
Tuberculosis: discovery of an ancestral lineage in the African Great Lakes region
![](/images/external-link.png)
GenoScreen launches a rapid, effective diagnostic kit, to combat tuberculosis antibiotic resistance
![](/images/external-link.png)
(French) Grippe : lutter contre les surinfections bactériennes grâce au microbiote
![](/images/external-link.png)
A major advance in the fight against multidrug-resistant tuberculosis
![](/images/external-link.png)
GenoScreen in the news
![](/images/slider170/team05_dots.png)
04/12/2023
GlobeNewswire - Global Biotechnology Instruments Market Size To Exceed USD 152.5 Billion by 2032 | CAGR of 8.1%
![](/images/external-link.png)
11/2023
WHO - Global Tuberculosis Report
![](/images/external-link.png)
09/2023
Institut Pasteur - 2022 Annual Report
![](/images/external-link.png)
08/2023
Market.us - Pharmacogenomics Market
![](/images/external-link.png)
07/2023
Medical Device Network - Illumina and Pillar collaborate to commercialise oncology assays
![](/images/external-link.png)
03/2023
Medtech Alert - Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa
![](/images/external-link.png)
05/01/2023
360dx - COVID-19 Still a Focus for Infectious Disease Test Developers in 2022, but Ceded Some Ground
![](/images/external-link.png)